References
Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19. Accessed April 1, 2023.
Marzolini C, Kuritzkes DR, Marra F, et al. Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions. Ann Intern Med. 2022;175(5):744-746. https://doi.org/10.7326/M22-0281.
Culas R, Nath S. Safely Prescribing Nirmatrelvir and Ritonavir-Avoiding Drug-Drug Interactions. JAMA Intern Med. 2023; https://doi.org/10.1001/jamainternmed.2022.6834.
Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications. https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/ritonavir-boosted-nirmatrelvir--paxlovid-/paxlovid-drug-drug-interactions/. Accessed 28 June 2023.
Ross SB, Bortolussi-Courval É, Hanula R, Lee TC, Goodwin Wilson M, McDonald EG. Drug Interactions With Nirmatrelvir-Ritonavir in Older Adults Using Multiple Medications. JAMA Netw Open. 2022;5(7):e2220184. https://doi.org/10.1001/jamanetworkopen.2022.20184.
Acknowledgements:
Funders: Dr. Anderson was supported by grant K76AG074878 from the National Institute on Aging.
Funding
National Institute on Aging,K76AG074878,Timothy S. Anderson
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest:
Dr. Anderson reports receiving grants from the American Heart Association, American College of Cardiology, US Deprescribing Research Network, and Boston OAIC Pepper Center outside of the submitted work. Dr. Herzig reports receiving grants from the Agency for Healthcare Research and Quality outside of the submitted work. Dr. Wang reports no conflicts of interest. Dr. Spetko reports no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Spetko, N., Wang, B.X., Herzig, S.J. et al. Prevalence and Management of Medication Interactions with Nirmatrelvir-Ritonavir at a Large Urban Academic Medical Center: An Observational Study. J GEN INTERN MED (2024). https://doi.org/10.1007/s11606-024-08750-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11606-024-08750-6